CS191276B2 - Process for preparing optically active or racemic omega-nor-cycloalkyl-13,14-dehydroprostaglandines - Google Patents
Process for preparing optically active or racemic omega-nor-cycloalkyl-13,14-dehydroprostaglandinesInfo
- Publication number
- CS191276B2 CS191276B2 CS755964A CS596475A CS191276B2 CS 191276 B2 CS191276 B2 CS 191276B2 CS 755964 A CS755964 A CS 755964A CS 596475 A CS596475 A CS 596475A CS 191276 B2 CS191276 B2 CS 191276B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- dehydroprostaglandines
- omega
- racemic
- cycloalkyl
- optically active
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4018—Esters of cycloaliphatic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/564—Three-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT27654/74A IT1053781B (it) | 1974-09-25 | 1974-09-25 | Omega nor cicloalcil 13.14 deidro prostaglandine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS191276B2 true CS191276B2 (en) | 1979-06-29 |
Family
ID=11222055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS755964A CS191276B2 (en) | 1974-09-25 | 1975-09-02 | Process for preparing optically active or racemic omega-nor-cycloalkyl-13,14-dehydroprostaglandines |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US4035415A (fi) |
| JP (2) | JPS5839156B2 (fi) |
| AT (1) | AT351184B (fi) |
| BE (1) | BE832983A (fi) |
| CA (1) | CA1083569A (fi) |
| CH (1) | CH617186A5 (fi) |
| CS (1) | CS191276B2 (fi) |
| CY (1) | CY954A (fi) |
| DE (1) | DE2539116C2 (fi) |
| DK (1) | DK155316C (fi) |
| FI (1) | FI63932C (fi) |
| FR (2) | FR2285866A1 (fi) |
| GB (1) | GB1483880A (fi) |
| HK (1) | HK42478A (fi) |
| HU (1) | HU174287B (fi) |
| IL (1) | IL48043A (fi) |
| IT (1) | IT1053781B (fi) |
| KE (1) | KE2851A (fi) |
| MY (1) | MY7800321A (fi) |
| NL (1) | NL187354C (fi) |
| NO (1) | NO146357C (fi) |
| SE (1) | SE422057B (fi) |
| SU (1) | SU652889A3 (fi) |
| ZA (1) | ZA755420B (fi) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU501803B2 (en) * | 1975-03-21 | 1979-06-28 | Farmitalia Carlo Erba S.P.A. | Fluoro-prostaglandins |
| DE2655004C3 (de) * | 1976-12-02 | 1980-06-19 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von bicyclischen Laktonen |
| IT1088966B (it) * | 1977-11-15 | 1985-06-10 | Erba Carlo Spa | 13,14-dideidro-prostaglandine |
| US4543353A (en) * | 1981-11-27 | 1985-09-24 | Farmitalia Carlo Erba S.P.A. | Ester and amide derivatives of 13,14-didehydro prostaglandins |
| JP2721414B2 (ja) * | 1988-09-06 | 1998-03-04 | フアーマシア・アンド・アツプジヨン・アー・ベー | 縁内障または眼圧亢進の治療のためのプロスタグランジン誘導体 |
| DE4024347A1 (de) * | 1990-07-27 | 1992-01-30 | Schering Ag | Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung |
| US5741810A (en) * | 1996-02-29 | 1998-04-21 | Allergan | Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents |
| CZ2013987A3 (cs) * | 2013-12-10 | 2015-06-17 | Univerzita Pardubice | Způsob přípravy (3aR,4S,5R,6aS)-4-[(3S)-5-cyklohexyl-3-hydroxypent-1-yn-1-yl]-5-(ethoxymethoxy)-hexahydro-2H-cyklopenta[b]furan-2-onu |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3843713A (en) * | 1972-04-05 | 1974-10-22 | Ciba Geigy Corp | 16-lower alkoxy lower alkyl,-16-20 w-pentano,pge |
| GB1425962A (en) * | 1972-04-13 | 1976-02-25 | Erba Carlo Spa | Lactols and lactones |
| US3876690A (en) * | 1973-05-11 | 1975-04-08 | American Cyanamid Co | 1-alkoxy-9-keto-prostenoic acid derivatives |
| US3884909A (en) * | 1973-09-24 | 1975-05-20 | Standard Brands Inc | Gelatinizable crosslinked cationic starch and method for its manufacture |
| IT1044796B (it) * | 1974-09-06 | 1980-04-21 | Erba Carlo Spa | Pgf beta gandolfi |
| FI71138C (fi) * | 1976-12-31 | 1986-11-24 | Erba Farmitalia | Foerfarande foer framstaellning av terapeutiskt aktiva bisykliska prostaglandiner |
-
1974
- 1974-09-25 IT IT27654/74A patent/IT1053781B/it active Protection Beyond IP Right Term
-
1975
- 1975-08-06 CY CY954A patent/CY954A/xx unknown
- 1975-08-06 GB GB32897/75A patent/GB1483880A/en not_active Expired
- 1975-08-08 US US05/603,015 patent/US4035415A/en not_active Expired - Lifetime
- 1975-08-25 AT AT656075A patent/AT351184B/de active
- 1975-08-25 ZA ZA755420A patent/ZA755420B/xx unknown
- 1975-08-25 JP JP50102845A patent/JPS5839156B2/ja not_active Expired
- 1975-08-29 DK DK390975A patent/DK155316C/da not_active IP Right Cessation
- 1975-09-02 CS CS755964A patent/CS191276B2/cs unknown
- 1975-09-02 BE BE159667A patent/BE832983A/xx not_active IP Right Cessation
- 1975-09-03 IL IL48043A patent/IL48043A/xx unknown
- 1975-09-03 NO NO753028A patent/NO146357C/no unknown
- 1975-09-03 SE SE7509764A patent/SE422057B/xx not_active IP Right Cessation
- 1975-09-03 DE DE2539116A patent/DE2539116C2/de not_active Expired
- 1975-09-03 FR FR7527034A patent/FR2285866A1/fr active Granted
- 1975-09-03 HU HU75EA152A patent/HU174287B/hu unknown
- 1975-09-04 CA CA234,796A patent/CA1083569A/en not_active Expired
- 1975-09-04 CH CH1149575A patent/CH617186A5/de not_active IP Right Cessation
- 1975-09-04 SU SU752170657A patent/SU652889A3/ru active
- 1975-09-04 NL NLAANVRAGE7510452,A patent/NL187354C/xx not_active IP Right Cessation
- 1975-09-04 FI FI752491A patent/FI63932C/fi not_active IP Right Cessation
-
1978
- 1978-03-24 FR FR7808815A patent/FR2378757A1/fr active Granted
- 1978-06-27 KE KE2851A patent/KE2851A/xx unknown
- 1978-08-03 HK HK424/78A patent/HK42478A/xx unknown
- 1978-12-30 MY MY321/78A patent/MY7800321A/xx unknown
-
1979
- 1979-02-02 US US06/009,091 patent/US4361577A/en not_active Expired - Lifetime
-
1982
- 1982-09-16 JP JP57159690A patent/JPS5918391B2/ja not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU82775A (en) | Process for preparing new n-phenyl-n-acyl-alanine or glycinesters | |
| HU173057B (hu) | Sposob poluchenija 1,3,4-trjokhzamehhjonnykh-4-fenil-piperidinov | |
| HU177952B (en) | Process for preparing new 5,9beta-disubstituted 2-tetrahydro-furfuryl-6,7-benzomorphanes | |
| YU81675A (en) | Process for preparing 1,1-diaryl-1-oxadiazole-alkylamines | |
| CH609323A5 (en) | Process for preparing optically active N-(2-benzhydrylethyl)-N-1-phenylethylamine | |
| HU171870B (hu) | Sposob poluchenija novykh 1,4-digidropiridinov | |
| CS191321B2 (en) | Process for preparing optically active 11-deoxy-16-aryloxy-omega-tetranorprostaglandines | |
| HU170888B (hu) | Sposob poluchenija novykh, opticheski aktivnykh proizvodnykh eburnameninov | |
| CS191276B2 (en) | Process for preparing optically active or racemic omega-nor-cycloalkyl-13,14-dehydroprostaglandines | |
| HU173985B (hu) | Sposob poluchenija proizvodnykh d-8al'fa,8beta-dvezamehhjonnogo-6-metil-ehrgolina i -ehrgolena | |
| NL7508428A (nl) | Werkwijze om polyolen te bereiden. | |
| YU40262B (en) | Process for preparing racemic or optically active 4-substituted | |
| CA1017741A (en) | Process for preparing 3-fluorocephalosporins | |
| JPS5328146A (en) | Process for preparing optically active aresrolone | |
| CS189001B2 (en) | Process for preparing optically active 13,14-dehydro-11-deoxyprostaglandines | |
| YU39750B (en) | Process for obtaining 2-deutero-3-fluoro-d,l-alanine | |
| NL7509206A (nl) | Werkwijze om polyolen te bereiden. | |
| CS191296B2 (en) | Process for preparing optically active or racemic fluorprostaglandine | |
| CS188965B2 (en) | Process for preparing 9-hydroxy-19,20-bis-nor-prostanic acid | |
| CS191994B2 (en) | Process for preparing 3,7-dimethyl-2,6-octadiennitrile | |
| YU119675A (en) | Process for preparing optical whiteners | |
| HU173528B (hu) | Sposob poluchenija steroid-skobka-16-al'fa,17-b-skobka zakryta-naftalinov | |
| HU171174B (hu) | Sposob poluchenija 3,7-dimetil-3-gidroksi-6-okten-nitrila | |
| JPS532460A (en) | Process for preparing optically active sulfoxide | |
| YU36916B (en) | Process for obtaining new 1-aryloxy-2-hydroxy-4-sec.amino-butanes |